Company profile: Distributed Bio
1.1 - Company Overview
Company description
- Provider of computational tools, antibody libraries, and an end-to-end antibody discovery and optimization platform for therapeutic programs, integrating target discovery through clinical development to address challenging targets including GPCRs, ion channels, pMHC complexes, condition-specific binders, anti-idiotypes, and broadly neutralizing viral epitopes.
Products and services
- Computational Tools: Computational platform architects target discovery across GPCRs, ion channels, and pMHC complexes, enabling identification of condition-specific binders, anti-idiotypes, and broadly neutralizing viral epitopes
- Antibody Libraries: Immuno-engineered libraries enable discovery of condition-specific binders, anti-idiotypes, and broadly neutralizing viral epitopes against challenging targets like GPCRs, ion channels, and pMHC complexes
- Antibody Discovery and Optimization Platform: End-to-end system for therapeutic antibody programs, integrating target discovery and clinical development to drug challenging targets—GPCRs, ion channels, pMHC complexes, and viral epitopes
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Distributed Bio
Evoxx Technologies
HQ: Germany
Website
- Description: Provider of industrial biotechnology solutions, focusing on the development and production of industrial enzymes and novel carbohydrate ingredients via enzymatic bioconversion. Offers proprietary enzymes and carbohydrate ingredients for high-growth markets addressing consumer needs in Global Food Health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evoxx Technologies company profile →
Cellink
HQ: Sweden
Website
- Description: Provider of bench-top bioprinters optimized for the bioprinting of human tissues.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellink company profile →
Ossiform
HQ: Denmark
Website
- Description: Provider of 3D bone printing solutions, including P3D Bone - bio-integrative, resorbable implants made from beta-tricalcium phosphate tailored to biomechanical needs; P3D Scaffolds - 3D printed bioceramic structures for cell culture, disease modeling, and drug screening; and Bone Printing Technology using beta-tricalcium phosphate to create implants with customizable porosity and mechanical properties.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ossiform company profile →
Centrillion Technologies
HQ: United States
Website
- Description: Provider of genomics and DNA analysis technologies for personalized medicine, life sciences research, and bioinformatics, offering whole genome genotyping assays; spatial transcriptomics at micron-scale resolution; high-throughput virus detection using ATOM chips; SARS-CoV-2 whole genome sequencing on QuadCore chips; VirusHunter assays for SARS-CoV-2 and Influenza A/B; and customizable ATOM chips for detecting pathogens, antibiotic resistance genes, and controls.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Centrillion Technologies company profile →
Reveal Biosciences
HQ: United States
Website
- Description: Provider of computational pathology diagnostics using AI to analyze large whole slide microscope images, combining a histopathology laboratory with machine learning to diagnose disease. Offers a new class of diagnostics with fundamental improvements in reach, cost, speed, accuracy, and scale in disease diagnosis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reveal Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Distributed Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Distributed Bio
2.2 - Growth funds investing in similar companies to Distributed Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Distributed Bio
4.2 - Public trading comparable groups for Distributed Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →